Mesna (Mesnex) Market Is Likely to Experience a Tremendous Growth by 2028
The global mesna (mesnex) market is anticipated to grow at a significant CAGR during the forecast period. The major factors that are expected to boost the market growth include an increase in incidences of cancer, coupled with the rising practices of chemotherapy, which has increased the demand for mesna. In 2018, cases of cancer were estimated to be 1,735,350 and this figure is estimated to grow by 3% every year. As a result, the chemotherapy is going through a phase of evolution and rapid progress. Ongoing clinical research for use in new treatment such as hemorrhagic cystitis is another factor that is accelerating the growth of the market along with increasing approvals by the FDA for new therapies, which are expected to open new doors for mesna.
To Request a Sample of our Report on Global
Mesna (Mesnex) Market: https://www.omrglobal.com/request-sample/mesna-market
Mesnex is sold by the trade name mesna. It is a thiol
compound that oxidizes rapidly in plasma to mesna disulfide, it is hydrophilic,
remains in the intravascular compartment, and is rapidly thrown by the kidneys.
Mesna is a drug used for the prevention of ifosfamide-induced hemorrhagic
cystitis and high-dose cyclophosphamide-induced hemorrhagic cystitis. It is
also prescribed after the chemotherapy to reduce the undesired side effects of
certain chemotherapy drugs. It is either injected through the vein or given as
a pill by mouth. Mesna is either consumed as a tablet or injected into the
veins in a dosage equal to 40% of the ifosfamide dose at two and six hours
after each dose of ifosfamide as a prophylactic agent to reduce the incidence
of ifosfamide-induced hemorrhagic cystitis in conjunction with standard
antineoplastic therapy. The daily dose of mesna is equal to 100% of the
ifosfamide dose.
Market Coverage
·
The market number available for – 2021-2028
·
Base year- 2021
·
Forecast period- 2022-2028
·
Segment Covered
·
Regions Covered- Globally
Competitive Landscape: Sagent Pharmaceuticals, Inc., Fresenius SE &
Co. KGaA, and Baxter International Inc., among others.
A
full Report of Global Mesna (Mesnex) Market is Available @ https://www.omrglobal.com/industry-reports/mesna-market
Global Mesna (Mesnex) Market Report Segmentation
By Type
•
Oral
•
Injections
By Application
•
Hospital Pharmacies
•
Retail Pharmacies
•
Online Pharmacies
Global Mesna (Mesnex) Market by Region
· United
States
· Canada
Europe
· UK
· Germany
· Spain
· France
· Italy
· Rest
of Europe
Asia-Pacific
· India
· China
· Japan
· South
Korea
· Rest
of APAC
Rest of the World
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data,
Request for Report Customization @ https://www.omrglobal.com/report-customization/mesna-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment